Pre-removal plasma levonorgestrel level and return ot fertility after levonorgestrel 52 mg intrauterine system discontinuation

Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.

OBJECTIVE To assess 3-year data on the efficacy and safety of a new 52-mg levonorgestrel intrauterine contraceptive (LNG20) designed for up to 7 years use. STUDY DESIGN Nulliparous and parous women aged 16-45 years at enrollment with regular menstrual cycles and requesting contraception were enrolled in an open-label, partially randomized trial to evaluate LNG20. The primary outcome was pregn...

TCRM_5624_The levonorgestrel-releasing intrauterine system

Correspondence: Paul D Blumenthal Department of Obstetrics and Gynecology, 300 Pasteur Drive, Stanford University Hospital, C/O Office of Obstetrics and Gynecology, Stanford, CA 94305, USA email [email protected] Abstract: The levonorgestrel-releasing intrauterine system (LNG-IUS) is a safe, effective and acceptable form of contraception used by over 150 million women worldwide. It also has ...

Menorrhagia and the Levonorgestrel Intrauterine System

Only half of the women who present to clinicians with heavy menstrual loss have objective menorrhagia. However, it is the main reason for women requesting hysterectomy and 1 in 5 women have a hysterectomy in the United Kingdom for this reason by the age of fifty five. At histopathology, a vast majority of these uteri are found to be benign. With less invasive and effective alternatives to hyste...

Bleeding patterns do not differ between obese and non-obese women using a levonorgestrel 52-mg intrauterine system

Levonorgestrel-releasing intrauterine system and new-onset acne.

We recently encountered 5 patients with new-onset acne after the placement of a levonorgestrel-releasing intrauterine system (LNG-IUS). The women ranged in age from 31 to 36 years and all developed inflammatory papules localized to the jawline and/or back 1 to 3 months after insertion of an LNG-IUS. None of the patients were aware that acne could be a side effect of the device. Therapy was init...